You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 231 No. 12, March 24, 1975 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (95)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Staphylococcus aureus Among Insulin-Injecting Diabetic Patients

An Increased Carrier Rate

Carmelita U. Tuazon, MD; Aurora Perez, MD; Tomokauzu Kishaba, MD; John N. Sheagren, MD

JAMA. 1975;231(12):1272.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN EARLIER studies, we attempted to define the source of the organism causing staphylococcal endocarditis in drug abusers who used the needle. Street heroin and injection paraphernalia were not implicated.1 We then found a 300% increase in the carrier rate of Staphylococcus aureus among those who had recently used drugs parenterally, compared to a control population who had not. Users who had not injected any drug for two weeks or more had the same carrier rate as the control group.2 The reason for the increased carrier rate in recent drug users was not apparent, although we suspected that it might have been related to the effect of drugs on resistance to the Staphylococcus or on such epidemiologic factors as poor hygiene or frequent needle use. To examine the possibility that epidemiologic factors were involved, we have examined members of another group of patients who inject themselves regularly with . . . [Full Text PDF of this Article]


Author Affiliations

From the Division of Infectious Diseases, Department of Medicine, Howard University College of Medicine, Washington, DC.


Footnotes

Read before the Interscience Conference on Antimicrobial Agents and Chemotherapy, Sept 11 through 13, 1974, San Francisco.

Reprint requests to Infectious Disease Unit, Howard University Medical Service, DC General Hospital, 19th and E streets SE, Washington, DC 20003 (Dr. Tuazon).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.